Canberra calls in a manufacturer to map out a future for the sector

By Peter Roberts The federal government has turned to former Dow chemical CEO Andrew Liveris to help map a new future for Australian manufacturing in the post-coronavirus world. Liveris, an Australian, has been called up by Canberra’s National COVID-19 Coordination Commission to devise a long-term strategy to deliver a competitive manufacturing sector to help in…

Myriota expands IoT reach into Canada

Nanosatellite developer Myriota has extended its reach in the Canadian market with the purchase of satellite communications assets from exactEarth Ltd. The acquisition will see Myriota Canada acquire four satellites, a global network of ground station assets, and their associated spectrum licenses. The acquisition will increase the Adelaide company’s capability to deliver low-cost, low-power, secure…

CSIRO begins testing Covid-19 vaccines as part of global effort

By Peter Roberts In an exciting development Australia’s CSIRO has begun testing potential vaccines against the Covid-19 coronavirus at its Australian Animal Health Laboratory (AAHL) facility in Geelong. Testing in the biosecure facility originally built to contain the world’s most harmful plant and animal diseases is part of a global effort led by the interational Coalition…

Noxopharm investigates Covid-19 treatment

Drug developer Noxopharm is following up on indications that an experimental anti-cancer drug may be effective against the Covid-19 coronavirus. Melbourne’s Hudson Institute of Medical Research has identified anti-inflammatory properties of the experimental drug idronoxil, the active ingredient in the company’s anti-cancer drug candidate Veyonda. Pre-clinical models indicate the drug has the ability to treat…